The core activity of Cures Health Care is the development, manufacture and export of pharmaceutical products, particularly generics and biosimilars, of both Swiss and non-Swiss origin. The company offers a wide range of medications, including tablets, capsules and injectable products, used to treat various diseases and conditions, such as hypertension, diabetes, anxiety disorders and cancer. Cures Health Care operates in over 12 countries worldwide, including the MENA region, Europe, the US and Canada, and collaborates with local licensees and government authorities to offer its products on the respective markets.